
Humanin
MOTS-c's older sibling.
- Sizes available
- —
- Lab certificate (COA)
- Arrives with shipment
· Research-grade only · Not for human consumption · 21+ ·
Mitochondrial cytoprotective peptide. Sister protein to MOTS-c.
Mechanism · 24-Aa mitochondrial-encoded peptide. Bcl-2/Bax inhibitor (anti-apoptotic).
Best for. Not for.
Best for
- Researchers focused on cytoprotection
- Mitochondrial peptide research participant
- Users open to stacking with MOTS-c
Not for
- Active malignancy, pregnancy, or nursing
- No human Phase 2 RCT. Animal / early human only
- Long-term safety is not established
Mechanism, dose, ramp, risk.
- Mechanism
- Mitochondrial-derived peptide. Cytoprotective.Source · PEPVERA editorial
- Target dose
- Research-only.Source · PEPVERA editorial
- Ramp
- Slow.Source · PEPVERA editorial
- Risks
- Limited human data.Source · PEPVERA editorial
Compared to its siblings.
Humanin
Mitochondrial cytoprotective peptide. Sister protein to MOTS-c.
Pros
- · Anti-apoptotic Bcl-2/Bax action absent in MOTS-c's metabolic pathway.
- · No missed Phase 3 endpoint like SS-31's MMPOWER-3.
Cons
- · Lacks MOTS-c's Lee USC research depth and exercise-mimetic data.
- · Animal-only evidence versus SS-31's Phase 3 trial program.
MOTS-c
Exercise mimetic. Metabolic homeostasis.
Pros
- · Lee USC research
Cons
- · Different mechanism (metabolic)
See MOTS-c →
SS-31 (elamipretide)
Targeted antioxidant (elamipretide).
Pros
- · Phase 3 trial data
Cons
- · MMPOWER-3 missed primary
See SS-31 (elamipretide) →
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 0 suppliers
No verified suppliers yet for this compound.
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Week 1–2
Research-only.
Initiation
Week 3–4
Research-only.
Signal emerges
Week 5–8
Research-only.
Hold
Week 9–12
Cycle review
Assess
Draw 20 units.
0.5 mg = 0.20 mL at 2.50 mg/mL. 10.0 doses per vial.
eternal · V
Humanin · 5mg